Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Atomoxetine

This article is a stubmissing:

Subjective Effects

Pharmacology

Interactions

Tolerance

History & Culture

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~10 mg

Light10-18 mg

Moderate18-40 mg

Strong40-80 mg

Heavy80+ mg

Duration

Onset15-45 minutes

After Effects2-24 hours

Total8-12 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check

TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Toxicity

Hepatic

Rare cases of severe liver injury, including liver failure requiring transplant, have been reported in postmarketing experience; clinical trials of approximately 6000 patients did not detect evidence of liver injury.

Cardiovascular

Patients receiving usual atomoxetine doses have had reports of sudden death, stroke, and myocardial infarction. The drug may increase blood pressure and heart rate and should be avoided in people with severe cardiac or vascular disease.

Psychosis Risk

Treatment-emergent psychotic or manic symptoms including hallucinations, delusional thinking, or mania can occur in children and adolescents without prior history of psychotic illness at usual doses. Mental changes including disorientation and hallucinations have been reported less commonly in overdose situations.

Seizure Risk

Seizures have been reported in some cases of overdose involving atomoxetine.

History & Culture

History & Culture not written up yet

Legality

By Country

Prescription2

United StatesPrescription only

CanadaPrescription only

References

Citations

Article Status

Step 1 · Automated synthesis
An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest 24 Jan

Times are UTCNewest first

24 January 2026

23:32
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
23:25
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
23:20
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
23:15
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
22:57
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
22:42
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
22:21
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Atomoxetine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.